AstraZeneca is ‘50% effective in preventing death’ from Covid-19

AstraZeneca is '50% effective in preventing death' from Covid-19

AstraZeneca’s Covid-19 drug AZD7442 reduced severe illness and death by 50% in non-hospitalized patients in a late-stage study. In today’s announcement, AstraZeneca, an Anglo-Swedish multinational pharmaceutical company with headquarters in Cambridge, said its antibody drug AZD7442 met the main goal …

Read more